CHARACTERISTICS AND CLINICAL MANIFESTATIONS OFE-CIGARETTE OR VAPING USE–ASSOCIATED LUNG INJURY (EVALI)
Keywords:
Characteristics, Clinical Manifestations, EVALIAbstract
Electronic cigarettes (e-cigarettes) have been the most commonly used tobacco products among young people since 2014. E-cigarettes are battery-operated devices that heat a liquid to produce an aerosol containing various active chemical substances. This study aimed to describe the characteristics and clinical manifestations of E-cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI). The study was conducted by collecting secondary data from multiple research journals published between 2020 and 2025. The results indicate that EVALI is a lung disease associated with the use of e-cigarettes or vaping products. The clinical manifestations of EVALI are heterogeneous but commonly include respiratory symptoms, constitutional symptoms (such as fever and fatigue), and gastrointestinal symptoms. EVALI is caused by exposure to chemical substances contained in vaping products, including tetrahydrocannabinol (THC), nicotine, and other additives. During the epidemic period, EVALI management has not yet had standardized guidelines regarding dosing and treatment stratification. The management of EVALI is divided into non-pharmacological and pharmacological approaches. The complexity of diagnostic procedures required for EVALI results in most diagnosed patients being hospitalized, with oxygen saturation levels below 95% at the time of hospital admission.
References
Amjad, M. A., Trujillo, D. O. et al. (2025). E-Cigarette or Vaping Product Use-Associated Lung Injury: A Comprehensive Review. Internasional Journal of Environmental Research and Public Health.
Abdallah, B., Lee, H., Weerakoon, S. M. et al. (2022). Clinical manifestations of EVALI in adolescents before and during the COVID‐19 pandemic. Pediatric Pulmonology.
Radhiah, P. (2020). Studi Literatur : Hubungan Vitamin E Asetat pada Rokok Elektrik dengan kejadian EVALI (E-Cigarette, or Vaping, Product Use Associated Lung injury). Jurnal Ilmu Kedokteran Dan Kesehatan.
Farhaeni, A., Wiarfa, N. A., Tania, L. Z. dkk. (2024). Penggunaan Rokok Elektrik terhadap Lung Impairment (Gangguan Fungsi Paru). Wiraraja Medika: Jurnal Kesehatan.
Werner, A. K., Koumans, E. H., Chatham-Stephens, K. et al. (2020). Hospitalizations and Deaths Associated with EVALI. The New England Journal of Medicine.
Ramdani, Y., Siwi, D. (2025). Penatalaksanaan penderita pneumonia akibat peran rokok elektrik pada usia remaja dengan pendekatan kedokteran keluarga pada layanan kesehatan primer. Jurnal Ilmiah Kesehatan.
Zulfiqar, H., Sankari, A., Rahman, O. (2025). Vaping-Associated Pulmonary Injury. Treasure Island (FL): StatPearls Publishing.
Widyantari, D. D., Lestari, R. (2023). Dampak Penggunaan Rokok Elektrik (Vape) terhadap Risiko Penyakit Paru. Lombok Medical Journal.
Furkan, M., Sabri, Y. S., Fitrina, D. W. (2023). E-Cigarette or Vaping Use-Associated Lung Injury. Majalah Kedokteran Andalas.
Wirajaya, M. K., Farmani, P. I., Laksmini, P. A. (2024). Determinan Penggunaan Rokok Elektrik (Vape) pada Kalangan Remaja di Indonesia. Jurnal Kesehatan Komunitas.
Krisdanti, I. D., Ghosali, A. (2024). Rokok elektrik dan tuberkulosis paru: sebuah tinjauan pustaka. Intisari Sains Medis.
Woen, A. W., Sumbayak, E. M. (2024). Tinjauan Pustaka Paparan Asap Rokok Elektrik (Vape) Terhadap Serebrum dan Perilaku Tikus. Jurnal MedScientiae.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 A.Muh. Nasywan Akbar , Edward Pandu Wiriansyah , Bulkis Natsir (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
